LENTECHS

📍 Columbus, United States🗓 Founded 2020👥 9 employees💰 Last funded 2023
LENTECHS, LLC is a privately-held, clinical stage ophthalmic medical device company focused on developing a new generation of soft, suspended contact lens, with a platform of offerings to span the patient lifecycle. Its flagship contact lens platform, APIOC™ has a patented design for suspension of the lens from behind the upper eyelid and is designed based on the anatomy of the eye. Collaboratively founded with its optometrist inventors Melissa Bailey, OD, PhD, and Joe Barr, OD, MS, FAAO, LENTECHS has successfully developed its core technology licensed from The Ohio State University. APIOC for Presbyopia and APIOC for Presbyopia with Astigmatism will launch in early-2022. This new generation of soft, suspended contact lens is designed to help Presbyopes achieve glasses-like vision with the freedom of a contact lens.™ LENTECHS was incorporated in 2017, is headquartered in Columbus, Ohio, and is funded by a network of investors committed to revolutionary innovation in contact lenses.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in LENTECHS?
LENTECHS has 1 investors on record on gritt.io, 1 mid-stage.
When did LENTECHS last raise funding?
The most recent investment in LENTECHS recorded on gritt.io was in 2023.
When was LENTECHS founded?
LENTECHS was founded in 2020.
What industry is LENTECHS in?
LENTECHS operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is LENTECHS based?
LENTECHS is headquartered in Columbus, United States.